Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OGEN
Stock Latest News
Company Announcements
Oragenics Highlights Investor Outreach at Micro-Cap Conference
8d ago
8K
OGEN
Premium
The Fly
Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002
1M ago
OGEN
Premium
Company Announcements
Oragenics begins Phase IIa dosing of concussion drug ONP-002 in Australia
1M ago
OGEN
Premium
Company Announcements
Oragenics Sets New 2025 Annual Shareholder Meeting Date
2M ago
8K
OGEN
Premium
The Fly
Oragenics receives audit opinion with going concern explanation
2M ago
OGEN
Premium
The Fly
Oragenics files annual report on Form 10-K
2M ago
OGEN
Premium
The Fly
Oragenics initiates Phase IIa clinical trial site activation
3M ago
OGEN
Premium
Company Announcements
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions
3M ago
OGEN
Premium
The Fly
Oragenics explores potential acquisition of additional assets in CNS space
3M ago
OGEN
Premium
The Fly
Oragenics receives HREC approval for Phase IIa trial of ONP-002 in Australia
3M ago
OGEN
Premium
The Fly
Oragenics previews targeted milestones for 2026
4M ago
OGEN
Premium
The Fly
Oragenics partners with Duck Flats Pharma to support FDA IND trial design
4M ago
OGEN
Premium
Company Announcements
Oragenics Extends At-the-Market Equity Sales Agreement
4M ago
8K
OGEN
Premium
The Fly
Oragenics files $100M mixed securities shelf
4M ago
OGEN
Premium
Company Announcements
Oragenics Adjusts Executive Compensation Plan
5M ago
8K
OGEN
Premium
Company Announcements
Oragenics Regains NYSE Compliance After Public Offering
7M ago
8K
OGEN
Premium
The Fly
Oragenics regains compliance with NYSE
7M ago
OGEN
Premium
The Fly
Oragenics, Receptor.AI partner to accelerate pipeline development
8M ago
OGEN
Premium
Company Announcements
Oragenics Appoints Natasha Giordano to Board of Directors
9M ago
8K
OGEN
Premium
The Fly
Oragenics reports Q2 EPS ($3.10) vs. ($15.27) last year.
10M ago
OGEN
Premium
The Fly
Oragenics selects South Star Research as its CRO for ONP-002 Phase IIa trial
10M ago
OGEN
Premium
The Fly
Oragenics announces manufacturing agreement with Sterling Pharma for ONP-002
11M ago
OGEN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
